Temasek-backed firm, Zydus may recast API, gelatine business of Sterling Biotech

By Sreeja Biswas

  • 27 Aug 2024
Premium
Pankaj Patel, chairman at Zydus Lifesciences Limited | Credit: Mint

The owners of Sterling Biotech--Generic drugmaker Zydus Lifesciences Ltd and private equity Temasek-backed Perfect Day......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Become a Premium member
Already a member? Click here to log in.